Literature DB >> 12655550

The molecular basis of phenylketonuria in Lithuania.

J Kasnauskiene1, S Giannattasio, P Lattanzio, L Cimbalistiene, V Kucinskas.   

Abstract

We report the spectrum of phenylalanine hydroxylase (PAH) gene mutations in patients with phenylketonuria (PKU) residing in Lithuania. A total of 184 independent chromosomes was investigated. R408W mutation was first analysed through restriction enzyme digestion of exon 12. The remaining uncharacterised PKU chromosomes were analysed by scanning the whole coding sequence of PAH gene by multiplex 'broad range' denaturing gradient gel electrophoresis. Mutations were identified by fluorescent automated sequencing or by restriction enzyme digestion analysis if an abnormal DGGE pattern was recognised. 21 different mutations were identified for 175 PKU chromosomes, with a mutation detection rate of 95%. The most common ones were R408W (73.5% chromosomes) and R158Q (7.0% chromosomes) whereas the remaining mutations appeared to be rare (relative frequencies 0.5%-2%). The high mutation detection rate obtained is an evidence of the efficiency of PAH genetic testing achieved in Lithuania. Moreover, the definition of the PKU mutation profile in the Lithuanian population will allow to perform a genotype-phenotype correlation study thus making feasible genotyped-based prediction of the biochemical phenotype in newborns with hyperphenylalaninemia. This may be useful for refining diagnosis and anticipating dietary requirements. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655550     DOI: 10.1002/humu.9113

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Hyperphenylalaninaemias in Estonia: Genotype-Phenotype Correlation and Comparative Overview of the Patient Cohort Before and After Nation-Wide Neonatal Screening.

Authors:  Hardo Lilleväli; Karit Reinson; Kai Muru; Kristi Simenson; Ülle Murumets; Tõnu Möls; Katrin Õunap
Journal:  JIMD Rep       Date:  2017-09-28

2.  Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance.

Authors:  M Kreile; O Lubina; I Ozola-Zalite; R Lugovska; N Pronina; O Sterna; P Vevere; M Konika; I Malniece; L Gailite
Journal:  Mol Genet Metab Rep       Date:  2020-10-20

3.  The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness.

Authors:  Gladys Ho; Ian Alexander; Kaustuv Bhattacharya; Barbara Dennison; Carolyn Ellaway; Sue Thompson; Bridget Wilcken; John Christodoulou
Journal:  JIMD Rep       Date:  2013-12-25

4.  Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.

Authors:  Polina Gundorova; Anna A Stepanova; Irina A Kuznetsova; Sergey I Kutsev; Aleksander V Polyakov
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

5.  Molecular analysis of exons 6 and 7 of phenylalanine hydroxylase gene mutations in Phenylketonuria patients in Western Iran.

Authors:  Keyvan Moradi; Reza Alibakhshi; Keyghobad Ghadiri; Saeid Reza Khatami; Hamid Galehdari
Journal:  Indian J Hum Genet       Date:  2012-09

6.  Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing.

Authors:  Nana Li; Haitao Jia; Zhen Liu; Jing Tao; Song Chen; Xiaohong Li; Ying Deng; Xi Jin; Jiaping Song; Liangtao Zhang; Yu Liang; Wei Wang; Jun Zhu
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

7.  Mutation analysis of the PAH gene in phenylketonuria patients from Rio de Janeiro, Southeast Brazil.

Authors:  Eduardo Vieira Neto; Francisco Laranjeira; Dulce Quelhas; Isaura Ribeiro; Alexandre Seabra; Nicole Mineiro; Lilian D M Carvalho; Lúcia Lacerda; Márcia G Ribeiro
Journal:  Mol Genet Genomic Med       Date:  2018-05-10       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.